Serum surfactant protein D may predict the effect of pirfenidone in idiopathic pulmonary fibrosis

被引:0
|
作者
Ikeda, Kimiyuki [1 ]
Shiratori, Masanori [1 ]
Yokoo, Keiki [1 ]
Ohtsuka, Mitsuo [1 ]
Chiba, Hirofumi [1 ]
Takahashi, Hiroki [1 ]
机构
[1] Sapporo Med Univ, Sch Med, Dept Internal Med 3, Sapporo, Hokkaido 0608543, Japan
关键词
Interstitial lung disease; Idiopathic pulmonary fibrosis; Treatments;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
2600
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Serum surfactant protein D predicts the outcome of patients with idiopathic pulmonary fibrosis treated with pirfenidone
    Ikeda, Kimiyuki
    Shiratori, Masanori
    Chiba, Hirofumi
    Nishikiori, Hirotaka
    Yokoo, Keiki
    Saito, Atsushi
    Hasegawa, Yoshihiro
    Kuronuma, Koji
    Otsuka, Mitsuo
    Yamada, Gen
    Takahashi, Hiroki
    RESPIRATORY MEDICINE, 2017, 131 : 184 - 191
  • [2] Serum surfactant protein D predicts the outcome of patients with idiopathic pulmonary fibrosis treated with pirfenidone
    Weng, Jie
    Tu, Mengyun
    Yang, Bo
    Wang, Zhiyi
    RESPIRATORY MEDICINE, 2018, 145 : 228 - 228
  • [3] Serum surfactant protein D as a prognostic factor in idiopathic pulmonary fibrosis
    Dawalat El-Miligy
    Mohamed W. Zakaria
    Laila Rashed
    Haidi Abu-Hussein
    Egyptian Journal of Bronchology, 2015, 9 (1) : 64 - 68
  • [4] SIGNIFICANCE OF SERUM SURFACTANT PROTEIN D FOR COMBINED PULMONARY FIBROSIS WITH EMPHYSEMA IN IDIOPATHIC PULMONARY FIBROSIS
    Yokoo, Keiki
    Shiratori, Masanori
    Natsuizaka, Motoki
    Ikeda, Kimiyuki
    Otsuka, Mitsuo
    Chiba, Hirohumi
    Yamada, Gen
    Koba, Hiroyuki
    Takahashi, Hiroki
    RESPIROLOGY, 2013, 18 : 198 - 198
  • [5] Serum Ccl-18 May Predict The Short-Term Response To Pirfenidone In Idiopathic Pulmonary Fibrosis
    Bonella, F.
    He, X.
    Ohshimo, S.
    Guzman, J.
    Wessendorf, T.
    Costabel, U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [6] Serum concentrations of surfactant proteins A and D predict mortality in patients with idiopathic pulmonary fibrosis
    Greene, KE
    Kuroki, Y
    Bartelson, BB
    King, TE
    Hunninghake, GW
    Parsons, PE
    Newman, LS
    Nagoe, H
    Tudor, R
    Kuhn, C
    Mason, RJ
    CHEST, 2001, 120 (01) : 72S - 72S
  • [7] A study of surfactant protein-D serum levels in patients with idiopathic pulmonary fibrosis
    Elashry, Fawzia E.
    Ibrahim, Ibrahim S.
    Bahr, Hoda M.
    Nagy, Halah M.
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2018, 67 (03): : 264 - 269
  • [8] Pirfenidone in idiopathic pulmonary fibrosis
    Swigris, J.
    Fairclough, D.
    EUROPEAN RESPIRATORY JOURNAL, 2010, 36 (03) : 695 - 696
  • [9] PIRFENIDONE IN IDIOPATHIC PULMONARY FIBROSIS
    Maher, T. M.
    DRUGS OF TODAY, 2010, 46 (07) : 473 - 482
  • [10] Pirfenidone In Idiopathic Pulmonary Fibrosis
    Carter, Natalie J.
    DRUGS, 2011, 71 (13) : 1721 - 1732